Clinical trial
The Targeting Acute Congestion With Tolvaptan In Congestive Heart Failure Study
NCT01644331 is registered in ClinicalTrials.gov with Duke University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Targeting Acute Congestion With Tolvaptan In Congestive Heart Failure Study
- Lead sponsor
- Duke University
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- October 31, 2012
- Completion date
- February 29, 2016
- Enrollment
- 257 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.